Recalls & Warnings April 15, 2003 FTC Requires Scientific Evidence for "Snore Formula" Claims On April 15 2003, the U.S
Laboratory studies suggest that these interactions may influence phosphorylation events and signal transduction processes that regulate endothelial behavior, vascular tone signaling, and angiogenic pathway activity
doi:10.1177/03635465251357593
doi: 10.3389/fnut.2025.1676080 Received 01 August 2025 Accepted 10 September 2025 Published 04 December 2025 Volume 12 - 2025 Edited by Lidia Daimiel, IMDEA Food Institute, Spain Reviewed by Juan Gerardo Reyes-Garca, Escuela Superior de Medicina (IPN), Mexico Sergio Adrin Terrasa, Italian Hospital of Buenos Aires, Argentina Updates Copyright 2025 Wirnitzer, Motevalli, Tanous, Drenowatz, Moser, Cramer, Rosemann, Wagner, Michalsen, Knechtle, Fras, Ritskes-Hoitinga, Marques, Mis, Stanford, Schubert, Goswami, Leitzmann, Fredriksen, Ruedl, Wilflingseder, Lima, Kessler, Jeitler, Khan, Joulaei, Fatemi, Knight, Kratky, Palmer, Haditsch, Jakse, Kofler, Pfeiffer, Cordova-Pozo, Tortella, Straub, Lynch, Schtzer, Krishnan, Fathima A., Gatterer, Kriwan, Abhishek, Nandgaonkar, Nandgaonkar, Adedara, Haro, Gericke, Neumann, Akhtar, Rashidlamir, Thangavelu, Ngoumou, Perpk, Klaper, Bhattacharya, Kirschner, Bessems, Jones, Peoples, Bescos, Duftner and Seifert

Some medical conditions influence whether methylcobalamin or cyanocobalamin is the more appropriate form